Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-15

Clinical Trial Update: Invasive Markers of Staphylococcus Epidermidis

View source ↗

Summary

This document reports on the completion of a clinical trial evaluating invasive markers in patients with Staphylococcus epidermidis-positive blood culture.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Staphylococcus Epidermidis Positive Blood Culture | Status: COMPLETED